Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-023909
Filing Date
2021-03-31
Accepted
2021-03-31 21:25:51
Documents
2
Period of Report
2021-03-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 18016
2 POA DOCUMENT poa.txt EX-24.4_976386 3512
  Complete submission text file 0001209191-21-023909.txt   22872
Mailing Address 8 CLARKE DRIVE CRANBURY NJ 08512
Business Address 8 CLARKE DRIVE CRANBURY NJ 08512 (609) 642-6664
PMV Pharmaceuticals, Inc. (Issuer) CIK: 0001699382 (see all company filings)

EIN.: 463218129 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PELOTON THERAPEUTICS, INC. 2330 INWOOD ROAD, SUITE 226 DALLAS TX 75235
Business Address
Schroeder Thilo (Reporting) CIK: 0001776412 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39539 | Film No.: 21795728